A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma
Recruiting now · Phase 3
Conditions studied: Multiple Myeloma
In brief
The purpose of this study is to evaluate how well JNJ-79635322 works when compared with an anti-B-cell maturation antigen (BCMA)xCD3 bispecific antibody.
Key facts
- Study ID
- NCT07258511
- Run by
- Janssen Research & Development, LLC
- People needed
- 400
- Starts
- 2026-02-04
- Expected to finish
- 2031-09-30
- Last updated by the study team
- 2026-07-31
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- UAMS — Little Rock, Arkansas, United States (enrolling)
- City of Hope Duarte — Duarte, California, United States (enrolling)
- City of Hope Orange County Lennar Foundation Cancer Center — Irvine, California, United States (enrolling)
- USC Norris Comprehensive Cancer Center — Los Angeles, California, United States (enrolling)
- University of California San Francisco — San Francisco, California, United States (enrolling)
- Colorado Blood Cancer Institute — Denver, Colorado, United States (enrolling)
- University of Connecticut Health Center — Farmington, Connecticut, United States (enrolling)
- Yale Cancer Center — New Haven, Connecticut, United States (enrolling)
- Florida Cancer Specialists & Research Institute — Fort Myers, Florida, United States (enrolling)
- Mayo Clinic Jacksonville — Jacksonville, Florida, United States (enrolling)
- Moffit Cancer center — Tampa, Florida, United States (enrolling)
- Emory University — Atlanta, Georgia, United States (enrolling)
- City of Hope Chicago — Zion, Illinois, United States (enrolling)
- University of Iowa Hospital and Clinics — Iowa City, Iowa, United States (enrolling)
- Mission Cancer Blood — Waukee, Iowa, United States (enrolling)
- University of Kansas Cancer Center — Kansas City, Kansas, United States (enrolling)
- Norton Cancer Institute — Louisville, Kentucky, United States (enrolling)
- University of Maryland School of Medicine — Baltimore, Maryland, United States (enrolling)
- Mayo Clinic Rochester — Rochester, Minnesota, United States (enrolling)
- Mount Sinai Brooklyn — Brooklyn, New York, United States (enrolling)
- NYU Winthrop — Mineola, New York, United States (enrolling)
- Mount Sinai Chelsea — New York, New York, United States (enrolling)
- Laura and Isaac Perlmutter Cancer Center NYU ACC — New York, New York, United States (enrolling)
- Icahn School of Medicine at Mount Sinai — New York, New York, United States (enrolling)
- Mayo Clinic Phoenix — Phoenix, Arizona, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.